Prospects for developing an accurate diagnostic biomarker panel for low prevalence cancers

BACKGROUND: Early detection screening of asymptomatic populations for low prevalence cancers requires a highly specific test in order to limit the cost and anxiety produced by falsely positive identifications. Most solid cancers are a heterogeneous collection of diseases as they develop from various...

Descripción completa

Detalles Bibliográficos
Autores principales: Firpo, Matthew A, Boucher, Kenneth M, Mulvihill, Sean J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137269/
https://www.ncbi.nlm.nih.gov/pubmed/25096727
http://dx.doi.org/10.1186/1742-4682-11-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137269/
https://www.ncbi.nlm.nih.gov/pubmed/25096727
http://dx.doi.org/10.1186/1742-4682-11-34

Ejemplares similares